Search
Recursion Pharmaceuticals Inc
RXRXAdd to Watchlist
4.350USD
+0.300+7.41%
Close 10-28 16:00（ET）
2.59BMarket Cap
LossP/E TTM
Pre-market 05:58 (ET)4.310USD-0.040-0.92%
Pre-market 05:58 (ET)Today
+7.41%
5 Days
+19.51%
1 Month
+17.57%
6 Months
+27.57%
Year to Date
+6.36%
1 Year
-26.40%
Key Figures
4.000Open
4.430High
7.96MVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
1.34%Turnover Ratio
4.050Prev. Close
3.993Low
34.40MTurnover
LossP/E Static
2.82P/B
0.00%Div Yield TTM
-42.33%ROA
6.10052wk High
164.44Volume Ratio
-463.66MNet Profit
594.73MShares
-1.1603EPS TTM
1.03Beta
-57.16%ROE
2.77052wk Low
17.28%Amplitude
-69.56%Gross Margin
2.59BMarket Cap
2.27Reward/Risk
4.61%Risk Rate
Recursion Pharmaceuticals Inc's Score
0.04vs previous score
Forecast6.86
Financial Health5.73
Technical5.60
Valuation Dimensions6.92
Institutional Confidence7.00
Risk Assessment3.55
Media Coverage
Coverage Level
Very Low
Very High
Neutral
Analyst Rating
Recursion Pharmaceuticals Inc Technical Analysis
Technical Indicators
Buy
Summary
Buy
Moving Average
Strong buy
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.25/-0.23
Revenue / Forecast
7.67M/11.95M
Recursion Pharmaceuticals Inc Profile
SectorBiotechnology & Medical Research
Ticker SymbolRXRX
Number of employees840
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| ARK Investment Management LLC | 7.66% |
| BlackRock Institutional Trust Company, N.A. | 6.06% |
| State Street Investment Management (US) | 5.43% |
| Baillie Gifford & Co. | 4.51% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 40.50% |
| Investment Advisor/Hedge Fund | 12.87% |
| Venture Capital | 4.66% |
| Hedge Fund | 3.10% |
Related Instruments
+0.50%
+0.86%
-0.14%
-0.63%
-0.50%
-0.34%
+0.87%
+0.08%
-0.98%
-1.17%
+1.66%
-1.59%
-0.67%
+0.84%
-4.32%
+2.98%
-0.35%
-0.59%
-0.69%
+1.05%Popular Instruments
52826.500
+236.600 (+0.45%)
29543.300
-55.600 (-0.19%)
7734.200
+8.600 (+0.11%)
12898.000
-74.000 (-0.57%)
64755.000
+503.000 (+0.78%)
6191.800
+20.800 (+0.34%)
100.932
-0.584 (-0.57%)
343.830
-3.270 (-0.94%)
215.380
-2.560 (-1.17%)
4032.940
-33.960 (-0.83%)
FAQs
What is the current price of Recursion Pharmaceuticals Inc (RXRX)?
The current price of Recursion Pharmaceuticals Inc (RXRX) is 4.35.
What is the symbol of Recursion Pharmaceuticals Inc?
The ticker symbol of Recursion Pharmaceuticals Inc is RXRX.
What is the 52-week high of Recursion Pharmaceuticals Inc?
The 52-week high of Recursion Pharmaceuticals Inc is 6.10.
What is the 52-week low of Recursion Pharmaceuticals Inc?
The 52-week low of Recursion Pharmaceuticals Inc is 2.77.
What is the market capitalization of Recursion Pharmaceuticals Inc?
The market capitalization of Recursion Pharmaceuticals Inc is 2.59B.
Is Recursion Pharmaceuticals Inc (RXRX) currently rated as Buy, Hold, or Sell?
According to analysts, Recursion Pharmaceuticals Inc (RXRX) has an overall rating of signal_hold, with a price target of 6.78.
What is the Earnings Per Share (EPS TTM) of Recursion Pharmaceuticals Inc (RXRX)?
The Earnings Per Share (EPS TTM) of Recursion Pharmaceuticals Inc (RXRX) is -1.16.